FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/06/034217 [Registered on: 14/06/2021] Trial Registered Prospectively
Last Modified On: 11/06/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Role of dexmedetomidine and magnesium sulphate in controlling the stress response of intubation in patients undergoing operation. 
Scientific Title of Study   A comparative study on dexmedetomidine and magnesium sulphate on the attenuation of the stress response of laryngoscopy and intubation in patients undergoing general anaesthesia. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Yangchen Bhutia 
Designation  Post graduate student 
Affiliation  Regional Institute of Medical Sciences 
Address  Department of Anaesthesiology, Regional Institute of Medical sciences.

Imphal West
MANIPUR
795004
India 
Phone  7908184386  
Fax    
Email  tansuflurries24@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanasam Sarat Singh 
Designation  Professor 
Affiliation  Regional Institute of Medical Sciences 
Address  Department of Anaesthesiology, Regional Institute of Medical Sciences.

Imphal West
MANIPUR
795004
India 
Phone  7005683433  
Fax    
Email  dr_saratsanasam@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Sanasam Sarat Singh 
Designation  Professor 
Affiliation  Regional Institute of Medical Sciences 
Address  Department of Anaesthesiology, Regional Institute of Medical Sciences.

Imphal West
MANIPUR
795004
India 
Phone  7005683433  
Fax    
Email  dr_saratsanasam@yahoo.co.in  
 
Source of Monetary or Material Support  
Regional Institute of Medical Sciences, Lamphelpat, Imphal-795004, Manipur, India. 
 
Primary Sponsor  
Name  Yangchen Bhutia 
Address  Post Graduate Trainee, Department of Anaesthesiology, Regional Institute of Medical Sciences, Lamphelpat, Imphal-795004, Manipur, India. 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Yangchen Bhutia  Regional Institute of Medical Sciences  Department of Anaesthesiology, Regional Institute of Medical Sciences.
Imphal West
MANIPUR 
7908184386

tansuflurries24@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Research Ethics Board, RIMS, Imphal  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 4||Measurement and Monitoring,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Injection Dexmedetomidine intravenous   Injection Dexmedetomidine 0.5ug/kg diluted to 10ml normal saline administered intravenously over 10 minutes before induction.  
Comparator Agent  Injection Magnesium sulphate intravenous   Injection Magnesium sulphate 20mg/kg diluted to 10ml normal saline administered intravenously over 1 minute before induction.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients of either sex
Patients with ASA physical grade I or II
Patients with age group 18 to 60 years undergoing elective surgery under general anesthesia
Patients willing to give written consent  
 
ExclusionCriteria 
Details  Patients refusal
Anticipated difficult airway (mallampati score >III, thyromental distance <6.5cm)
Patients with diabetes and hypertension
Pregnant or breast feeding mother
Patients with respiratory, cardiac,neurological,renal or liver diseases
Patients with gastro-oesophageal reflux
Patients with known allergy to drugs used for induction of anaesthesia
Psychiatric patients
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare efficacy of dexmedetomidine and magnesium sulphate on the attenuation of stress response of laryngoscopy and intubation in patients undergoing general anaesthesia.   Baseline
Before intubation, just after intubation ,and also at 1,3,5,10 minutes after intubation.  
 
Secondary Outcome  
Outcome  TimePoints 
To compare between dexmedetomidine and magnesium sulphate, a better drug for controlling the stress response.   Baseline
Before intubation, just after intubation, and also at 1,3,5,10 minutes after intubation 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/06/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a randomized,  parallel group,  placebo controlled double blinded trial to evaluate and compare the stress response attenuation between dexmedetomidine and magnesium sulphate in patients undergoing laryngoscopy and intubation. The study will be conducted in Department of Anaesthesiology, Regional institute of medical sciences, Imphal, Manipur, India. A total of 90 patients aged 18-60 years of either sex, ASA grade I and II will be randomly divided into three groups of 30 each and will be administered with the study drugs intravenously. Group D will receive Injection dexmedetomidine 0.5ug/kg diluted to 10ml normal saline, Group M will receive magnesium sulphate 20mg/kg diluted to 10ml normal saline and Group S will receive 10ml normal saline. Endotracheal intubation will be attempted and hemodynamic changes and adverse effects will be noted in each group, before, just after intubation and also at 1,3,5,10 minutes after intubation.  
Close